Veradermics, Inc (MANE)
About Veradermics, Inc
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$70.0M
- Total assets
- $152.6M
- Market cap
- $3.8B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $3.8B
- Shares outstanding
- 35.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Feb 4, 2026
Veradermics, Inc (MANE) Stock Price
- Reported a net loss of $70.0M.
- Trading 16% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Veradermics, Inc.
Write a review
Veradermics, Inc: frequently asked questions
Is Veradermics, Inc an American company?
Veradermics, Inc is a US-based company headquartered in New Haven, Connecticut, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Veradermics, Inc headquartered?
Veradermics, Inc is headquartered in New Haven, Connecticut, United States.
Is Veradermics, Inc publicly traded?
Yes — Veradermics, Inc is a publicly traded company. Its stock trades under the ticker symbol MANE on the NYSE.
What does Veradermics, Inc do?
Veradermics, Inc is an American Pharmaceuticals company in the Health & Beauty sector.
